Последние добавленные видео:
Lynparza
-
9 years ago
5835 9 years ago 2:45About Ovarian Cancer Treatment Lynparza
-
4 years ago
4405 4 years ago 3:25What Is Lynparza and How Does It Work in Prostate Cancer? | Ask a Prostate Expert, Mark Scholz, MD
-
9 months ago
349 9 months ago 7:10Dr. Carlos Doti Explains How AstraZeneca's LYNPARZA Has Changed Oncology
-
1 year ago
41559 1 year ago 23:14Management strategies for one adverse event from experienced nurse practitioners: Episode 3
-
4 years ago
2109 4 years ago 2:15Prostate Cancer News: Lynparza & Rubraca
-
4 years ago
781 4 years ago 2:00Dr. Zakashansky on the Benefit of Maintenance Olaparib in BRCA+ Ovarian Cancer
-
1 year ago
555 1 year ago 4:28FDA clears Lynparza for prostate cancer treatment
-
1 year ago
121828 1 year ago 17:33Key insights into long-term data for monotherapy from a leading expert
-
8 months ago
6213 8 months ago 6:53The story of olaparib: a life-saving cancer drug
-
1 year ago
82402 1 year ago 19:50Management strategies for one adverse event from experienced nurse practitioners: Episode 2
-
3 years ago
857 3 years ago 1:10OLYMPIA TRIAL LYNPARZA STOPS EARLY BREAST CANCER FROM COMING BACK
-
4 years ago
1294 4 years ago 3:10What is Maintenance therapy with Lynparza plus Avastin ? | OncoPower
-
3 years ago
5246 3 years ago 1:46Drug shows promise in treating aggressive form of breast cancer l GMA
-
5 years ago
614 5 years ago 1:32PARP Inhibitor Olaparib Exceeds Expectations in BRCA+ Pancreatic Cancer Management
-
5 years ago
574 5 years ago 2:12New drug could be ‘game changing’ in fight against genetic ovarian cancer | 5 News
-
5 years ago
6119 5 years ago 1:46Anne talks about ovarian cancer and drug olaparib
-
5 years ago
3393 5 years ago 5:14Olaparib and Keytruda For Advanced Prostate Cancer | | Learn About Clinical Trials
-
7 years ago
411 7 years ago 2:30Dr. Matulonis on Toxicities With PARP Inhibitors in Ovarian Cancer
-
6 years ago
1294 6 years ago 5:43Using Olaparib in gBRCA1/2+ Breast Cancer
-
1 year ago
65288 1 year ago 20:09Management strategies for one adverse event from experienced nurse practitioners: Episode 1